Gynecology Robotic Surgery Market Report 2026

The gynecology robotic surgery market size has grown strongly in recent years. It will grow from $3.24 billion in 2025 to $3.55 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing prevalence of gynecological disorders, rising patient preference for minimally invasive surgery, expansion of robotic surgery installations in hospitals, improved clinical outcomes from robotic-assisted procedures, growth in surgical specialization.

The gynecology robotic surgery market size is expected to see strong growth in the next few years. It will grow to $5.05 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing adoption of next-generation robotic platforms, rising investments in autonomous surgical systems, expansion of robotic surgery in outpatient settings, growing demand for precision-driven gynecological care, increasing integration of AI-assisted surgical planning. Major trends in the forecast period include increasing adoption of robotic-assisted gynecological procedures, rising demand for minimally invasive surgical techniques, expansion of robotic platforms in oncology applications, growing focus on surgeon training and skill enhancement, enhanced integration of advanced imaging and navigation systems.

The rising prevalence of gynecological diseases is expected to drive the growth of the gynecology robotic surgery market in the coming years. Gynecological diseases are medical conditions affecting female reproductive organs such as the uterus, ovaries, and cervix, impacting reproductive health and overall well-being. Their increasing incidence is partly attributed to lifestyle factors, including poor diet, lack of physical activity, and rising obesity rates, which can disrupt hormonal balance and reproductive function. Robotic surgery in gynecology provides a minimally invasive and highly precise treatment option, reducing pain, bleeding, and recovery time in procedures for conditions such as fibroids, endometriosis, and gynecologic cancers. For example, in January 2025, Cancer Australia, an Australia-based government agency, reported that gynecological cancers caused 2,171 deaths in 2022 and an estimated 2,235 deaths in 2024, with women having a 1 in 73 (1.4%) lifetime risk of dying from these cancers by age 85. Therefore, the increasing prevalence of gynecological diseases is propelling the growth of the gynecology robotic surgery market.

Leading companies in the gynecology robotic surgery market are developing next-generation robotic-assisted surgery systems to improve surgical precision, reduce operative times, and enhance patient recovery compared with conventional laparoscopic or open procedures. Robotic surgical systems combine advanced robotic arms, 3D high-definition visualization, and surgeon-controlled instruments to deliver superior dexterity, stability, and access in minimally invasive surgeries. For instance, in October 2025, Medtronic Plc, a US-based medical technology company, launched its third IDE study for the Hugo Robotic Surgery System targeting gynecologic procedures. The Hugo system features modular robotic arms, ergonomic surgeon consoles, and integrated imaging and instruments, enabling surgeons to perform complex procedures with enhanced precision, real-time visualization, and smaller incisions. Its applications include hysterectomies, myomectomies, and other minimally invasive gynecologic surgeries, offering benefits such as reduced blood loss, shorter hospital stays, faster recovery, and improved surgical accuracy.

In August 2024, KARL STORZ SE & Co. KG, a Germany-based provider of endoscopy and minimally invasive surgical solutions, acquired Asensus Surgical, Inc. for an undisclosed amount. This acquisition allows KARL STORZ to integrate Asensus Surgical’s digital laparoscopic platform into its portfolio, enhancing surgical precision, intelligence, and workflow efficiency in operating rooms worldwide. Asensus Surgical, Inc., based in the US, develops performance-guided robotic surgery systems.

Major companies operating in the gynecology robotic surgery market are Medtronic PLC, Stryker Corporation, Intuitive Surgical Inc., KARL STORZ SE & Co. KG, Sina Robotics And Medical Innovators Co. Ltd., CMR Surgical Limited, SS Innovations International Inc., Distalmotion SA, Ronovo Surgical Inc., Levita Magnetics International Corp., Titan Medical Inc., Virtual Incision Corporation, Nanjing Perlove Medical Equipment Co. Ltd., Edge Medical Robotics Corporation, Momentis Surgical Ltd., Virtuoso Surgical Inc., Moon Surgical SAS, GynoBotics Inc., Harbin Sagebot Intelligent Medical Equipment Co. Ltd., Asensus Surgical Inc., Medicaroid Corporation.

North America was the largest region in the gynecology robotic surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gynecology robotic surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gynecology robotic surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the gynecology robotic surgery market by increasing costs of imported robotic platforms, surgical instruments, imaging components, and software systems required for advanced procedures. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported high-value robotic systems, while Asia-Pacific faces higher acquisition costs for expanding robotic surgery programs. These tariffs are raising capital investment requirements and slowing system adoption. However, they are also encouraging localized assembly, regional service support expansion, and increased focus on cost-efficient robotic surgery solutions.

The gynecology robotic surgery market research report is one of a series of new reports that provides gynecology robotic surgery market statistics, including gynecology robotic surgery industry global market size, regional shares, competitors with a gynecology robotic surgery market share, detailed gynecology robotic surgery market segments, market trends and opportunities, and any further data you may need to thrive in the gynecology robotic surgery industry. This gynecology robotic surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Gynecology robotic surgery is a minimally invasive surgical technique that utilizes advanced robotic systems to assist surgeons in performing procedures on the female reproductive system with improved accuracy, control, and visualization. This approach allows for precise operations through small incisions, often resulting in reduced postoperative pain, shorter hospital stays, faster recovery, and a lower risk of complications compared with traditional open surgery.

The primary types of products in gynecology robotic surgery include robotic platforms, instruments and accessories, and robotic platform services. Robotic platforms are the core hardware and software systems that enable robotic-assisted surgeries, comprising robotic arms, control consoles, vision systems, and integrated imaging technologies. These platforms are applied across various gynecological procedures, including benign gynecologic surgeries and gynecologic oncology procedures, with applications such as hysterectomy, myomectomy, oophorectomy, sacrocolpopexy, and others. Key end users include hospitals, ambulatory surgical centers, and specialty clinics.

The gynecology robotic surgery market consists of revenues earned by entities by providing services such as robotic surgery consultation, preoperative imaging integration, intraoperative navigation support, postoperative monitoring, and surgical training programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The gynecology robotic surgery market also includes sales of products, such as robotic camera systems, 3D vision systems, surgical simulators, ergonomic surgeon consoles, and integrated energy instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.